Cleerly

Recent Finacing

Series C

Recent Raise

$192M

Cleerly provides an AI-enabled, FDA-cleared platform that analyzes coronary CT angiography to quantify and characterize atherosclerotic plaque, offering clinician-facing analytics, patient-facing education tools, and longitudinal tracking.